{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T08:16:53Z","timestamp":1778141813329,"version":"3.51.4"},"reference-count":154,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s12035-026-05901-0","type":"journal-article","created":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T02:30:26Z","timestamp":1778121026000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Advancements in Gene Delivery using Nucleic Acid Loaded Nanoparticles for Region Specific Delivery in Alzheimer\u2019s Disease"],"prefix":"10.1007","volume":"63","author":[{"given":"Vanktesh","family":"Kumar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Violina","family":"Kakoty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pankaj","family":"Wadhwa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,5,7]]},"reference":[{"key":"5901_CR1","doi-asserted-by":"crossref","unstructured":"Weis S, Sonnberger M, Dunzinger A, Voglmayr E, Aichholzer M, Kleiser R, Strasser P (2019) Neurodegenerative diseases: Alzheimer disease (AD). In: Imaging brain diseases: a neuroradiology, nuclear medicine, neurosurgery, neuropathology and molecular biology-based approach. Springer, pp 897\u2013931","DOI":"10.1007\/978-3-7091-1544-2_32"},{"key":"5901_CR2","volume-title":"Navigating neurodegeneration: integrating biomarkers, neuroinflammation, and imaging in Parkinson\u2019s, Alzheimer\u2019s, and motor neuron disorders","author":"M Tanaka","year":"2025","unstructured":"Tanaka M, Battaglia S, Liloia D (2025) Navigating neurodegeneration: integrating biomarkers, neuroinflammation, and imaging in Parkinson\u2019s, Alzheimer\u2019s, and motor neuron disorders, vol 13. MDPI"},{"issue":"10","key":"5901_CR3","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.1111\/ene.14393","volume":"27","author":"P Masrori","year":"2020","unstructured":"Masrori P, Van Damme P (2020) Amyotrophic lateral sclerosis: a clinical review. Eur J Neurol 27(10):1918\u20131929","journal-title":"Eur J Neurol"},{"key":"5901_CR4","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.nbd.2018.05.015","volume":"122","author":"PP Lie","year":"2019","unstructured":"Lie PP, Nixon RA (2019) Lysosome trafficking and signaling in health and neurodegenerative diseases. Neurobiol Dis 122:94\u2013105","journal-title":"Neurobiol Dis"},{"key":"5901_CR5","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/B978-0-12-800149-3.00002-0","volume":"87","author":"B Kantor","year":"2014","unstructured":"Kantor B, McCown T, Leone P, Gray SJ (2014) Clinical applications involving CNS gene transfer. Adv Genet 87:71\u2013124","journal-title":"Adv Genet"},{"issue":"36","key":"5901_CR6","doi-asserted-by":"publisher","first-page":"16962","DOI":"10.1039\/C8NR04073G","volume":"10","author":"N Poovaiah","year":"2018","unstructured":"Poovaiah N, Davoudi Z, Peng H, Schlichtmann B, Mallapragada S, Narasimhan B, Wang Q (2018) Treatment of neurodegenerative disorders through the blood\u2013brain barrier using nanocarriers. Nanoscale 10(36):16962\u201316983","journal-title":"Nanoscale"},{"issue":"7","key":"5901_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines12071523","volume":"12","author":"\u017b S\u0142yk","year":"2024","unstructured":"S\u0142yk \u017b, Stachowiak N, Ma\u0142ecki M (2024) Recombinant adeno-associated virus vectors for gene therapy of the central nervous system: delivery routes and clinical aspects. Biomedicines 12(7):1523","journal-title":"Biomedicines"},{"issue":"8","key":"5901_CR8","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.3390\/pharmaceutics17081041","volume":"17","author":"H-M Yang","year":"2025","unstructured":"Yang H-M (2025) Overcoming the blood\u2013brain barrier: advanced strategies in targeted drug delivery for neurodegenerative diseases. Pharmaceutics 17(8):1041","journal-title":"Pharmaceutics"},{"key":"5901_CR9","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.jconrel.2015.12.034","volume":"223","author":"BP Mead","year":"2016","unstructured":"Mead BP, Mastorakos P, Suk JS, Klibanov AL, Hanes J, Price RJ (2016) Targeted gene transfer to the brain via the delivery of brain-penetrating DNA nanoparticles with focused ultrasound. J Control Release 223:109\u2013117","journal-title":"J Control Release"},{"issue":"6","key":"5901_CR10","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1038\/s41565-021-00898-0","volume":"16","author":"JA Kulkarni","year":"2021","unstructured":"Kulkarni JA, Witzigmann D, Thomson SB, Chen S, Leavitt BR, Cullis PR, van der Meel R (2021) The current landscape of nucleic acid therapeutics. Nat Nanotechnol 16(6):630\u2013643","journal-title":"Nat Nanotechnol"},{"issue":"7","key":"5901_CR11","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1038\/s41419-022-05075-2","volume":"13","author":"Y Zhu","year":"2022","unstructured":"Zhu Y, Zhu L, Wang X, Jin H (2022) RNA-based therapeutics: an overview and prospectus. Cell Death Dis 13(7):644. https:\/\/doi.org\/10.1038\/s41419-022-05075-2","journal-title":"Cell Death Dis"},{"key":"5901_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.112265","volume":"145","author":"S Najafi","year":"2022","unstructured":"Najafi S, Tan SC, Raee P, Rahmati Y, Asemani Y, Lee EHC, Hushmandi K, Zarrabi A, et al. (2022) Gene regulation by antisense transcription: a focus on neurological and cancer diseases. Biomed Pharmacother 145:112265. https:\/\/doi.org\/10.1016\/j.biopha.2021.112265","journal-title":"Biomed Pharmacother"},{"issue":"5","key":"5901_CR13","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.3390\/pharmaceutics15051450","volume":"15","author":"M Lin","year":"2023","unstructured":"Lin M, Qi X (2023) Advances and challenges of stimuli-responsive nucleic acids delivery system in gene therapy. Pharmaceutics 15(5):1450","journal-title":"Pharmaceutics"},{"issue":"30","key":"5901_CR14","doi-asserted-by":"publisher","first-page":"6345","DOI":"10.1002\/adma.201600554","volume":"28","author":"R Zhang","year":"2016","unstructured":"Zhang R, Li Y, Hu B, Lu Z, Zhang J, Zhang X (2016) Traceable nanoparticle delivery of small interfering RNA and retinoic acid with temporally release ability to control neural stem cell differentiation for Alzheimer\u2019s disease therapy. Adv Mater 28(30):6345\u20136352","journal-title":"Adv Mater"},{"issue":"6","key":"5901_CR15","doi-asserted-by":"publisher","first-page":"250","DOI":"10.62347\/BPTG6174","volume":"13","author":"A Naghshbandieh","year":"2024","unstructured":"Naghshbandieh A, Naghshbandieh A, Barfi E, Abkhooie L (2024) Assessment of the level of apoptosis in differentiated pseudo-neuronal cells derived from neural stem cells under the influence of various inducers. Am J Stem Cells 13(6):250","journal-title":"Am J Stem Cells"},{"issue":"43","key":"5901_CR16","doi-asserted-by":"publisher","first-page":"16111","DOI":"10.1021\/ja404900k","volume":"135","author":"T Berbasova","year":"2013","unstructured":"Berbasova T, Nosrati M, Vasileiou C, Wang W, Lee KSS, Yapici I, Geiger JH, Borhan B (2013) Rational design of a colorimetric pH sensor from a soluble retinoic acid chaperone. J Am Chem Soc 135(43):16111\u201316119","journal-title":"J Am Chem Soc"},{"issue":"42","key":"5901_CR17","doi-asserted-by":"publisher","first-page":"15682","DOI":"10.1021\/ja4071738","volume":"135","author":"S Shah","year":"2013","unstructured":"Shah S, Solanki A, Sasmal PK, Lee K-B (2013) Single vehicular delivery of siRNA and small molecules to control stem cell differentiation. J Am Chem Soc 135(42):15682\u201315685","journal-title":"J Am Chem Soc"},{"issue":"1","key":"5901_CR18","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/s41392-022-01298-z","volume":"8","author":"Z-G Lu","year":"2023","unstructured":"Lu Z-G, Shen J, Yang J, Wang J-W, Zhao R-C, Zhang T-L, Guo J, Zhang X (2023) Nucleic acid drug vectors for diagnosis and treatment of brain diseases. Signal Transduct Target Ther 8(1):39","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"5901_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-025-03352-8","volume":"23","author":"S Mehdizadeh","year":"2025","unstructured":"Mehdizadeh S, Mamaghani M, Hassanikia S, Pilehvar Y, Ertas YN (2025) Exosome-powered neuropharmaceutics: unlocking the blood-brain barrier for next-gen therapies. J Nanobiotechnol 23(1):329. https:\/\/doi.org\/10.1186\/s12951-025-03352-8","journal-title":"J Nanobiotechnol"},{"issue":"1","key":"5901_CR20","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1056\/NEJMoa2212948","volume":"388","author":"CH van Dyck","year":"2023","unstructured":"van Dyck CH, Swanson CJ, Aisen P, Bateman RJ, Chen C, Gee M, Kanekiyo M, Li D, et al. (2023) Lecanemab in early Alzheimer\u2019s disease. N Engl J Med 388(1):9\u201321. https:\/\/doi.org\/10.1056\/NEJMoa2212948","journal-title":"N Engl J Med"},{"issue":"18","key":"5901_CR21","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1056\/NEJMoa2100708","volume":"384","author":"MA Mintun","year":"2021","unstructured":"Mintun MA, Lo AC, Duggan Evans C, Wessels AM, Ardayfio PA, Andersen SW, Shcherbinin S, Sparks J et al (2021) Donanemab in early Alzheimer\u2019s disease. N Engl J Med 384(18):1691\u20131704. https:\/\/doi.org\/10.1056\/NEJMoa2100708","journal-title":"N Engl J Med"},{"issue":"2","key":"5901_CR22","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/nrneurol.2009.219","volume":"6","author":"CA Lemere","year":"2010","unstructured":"Lemere CA, Masliah E (2010) Can Alzheimer disease be prevented by amyloid-beta immunotherapy? Nat Rev Neurol 6(2):108\u2013119. https:\/\/doi.org\/10.1038\/nrneurol.2009.219","journal-title":"Nat Rev Neurol"},{"issue":"6","key":"5901_CR23","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1016\/j.neuron.2014.12.064","volume":"85","author":"T Wisniewski","year":"2015","unstructured":"Wisniewski T, Go\u00f1i F (2015) Immunotherapeutic approaches for Alzheimer\u2019s disease. Neuron 85(6):1162\u20131176. https:\/\/doi.org\/10.1016\/j.neuron.2014.12.064","journal-title":"Neuron"},{"issue":"11","key":"5901_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines9111278","volume":"9","author":"V Vassilakopoulou","year":"2021","unstructured":"Vassilakopoulou V, Karachaliou C-E, Evangelou A, Zikos C, Livaniou E (2021) Peptide-based vaccines for neurodegenerative diseases: recent endeavors and future perspectives. Vaccines 9(11):1278","journal-title":"Vaccines"},{"issue":"5","key":"5901_CR25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1000491","volume":"5","author":"UP Dav\u00e9","year":"2009","unstructured":"Dav\u00e9 UP, Akagi K, Tripathi R, Cleveland SM, Thompson MA, Yi M, Stephens R, Downing JR et al (2009) Murine leukemias with retroviral insertions at Lmo2 are predictive of the leukemias induced in SCID-X1 patients following retroviral gene therapy. PLoS Genet 5(5):e1000491","journal-title":"PLoS Genet"},{"key":"5901_CR26","doi-asserted-by":"publisher","DOI":"10.1172\/jci35798","author":"SJ Howe","year":"2008","unstructured":"Howe SJ, Mansour MR, Schwarzwaelder K, Bartholomae C, Hubank M, Kempski H, Brugman MH, Pike-Overzet K et al (2008) Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients. J Clin Invest. https:\/\/doi.org\/10.1172\/jci35798","journal-title":"J Clin Invest"},{"issue":"11","key":"5901_CR27","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.1038\/mt.2009.223","volume":"17","author":"CT Deakin","year":"2009","unstructured":"Deakin CT, Alexander IE, Kerridge I (2009) Accepting risk in clinical research: is the gene therapy field becoming too risk-averse? Mol Ther 17(11):1842\u20131848","journal-title":"Mol Ther"},{"key":"5901_CR28","doi-asserted-by":"publisher","unstructured":"Ahmed B, Zafar M, Qadir MI (2019) Review: Oncogenic insertional mutagenesis as a consequence of retroviral gene therapy for X-linked severe combined immunodeficiency disease. Crit Rev Eukaryot Gene Expr 29(6):511\u2013520. https:\/\/doi.org\/10.1615\/CritRevEukaryotGeneExpr.2019026820","DOI":"10.1615\/CritRevEukaryotGeneExpr.2019026820"},{"issue":"6","key":"5901_CR29","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1038\/mt.2016.55","volume":"24","author":"S Zhou","year":"2016","unstructured":"Zhou S, Fatima S, Ma Z, Wang Y-D, Lu T, Janke LJ, Du Y, Sorrentino BP (2016) Evaluating the safety of retroviral vectors based on insertional oncogene activation and blocked differentiation in cultured thymocytes. Mol Ther 24(6):1090\u20131099","journal-title":"Mol Ther"},{"issue":"4","key":"5901_CR30","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.ymthe.2006.05.005","volume":"14","author":"KS Bankiewicz","year":"2006","unstructured":"Bankiewicz KS, Forsayeth J, Eberling JL, Sanchez-Pernaute R, Pivirotto P, Bringas J, Herscovitch P, Carson RE et al (2006) Long-term clinical improvement in MPTP-lesioned primates after gene therapy with AAV-hAADC. Mol Ther 14(4):564\u2013570","journal-title":"Mol Ther"},{"issue":"4","key":"5901_CR31","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1042\/EBC20180038","volume":"63","author":"S Minchin","year":"2019","unstructured":"Minchin S, Lodge J (2019) Understanding biochemistry: structure and function of nucleic acids. Essays Biochem 63(4):433\u2013456","journal-title":"Essays Biochem"},{"issue":"1","key":"5901_CR32","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1002\/jimd.12270","volume":"44","author":"HA Zittersteijn","year":"2021","unstructured":"Zittersteijn HA, Gon\u00e7alves MA, Hoeben RC (2021) A primer to gene therapy: progress, prospects, and problems. J Inherit Metab Dis 44(1):54\u201371","journal-title":"J Inherit Metab Dis"},{"issue":"28","key":"5901_CR33","doi-asserted-by":"publisher","first-page":"10343","DOI":"10.1523\/JNEUROSCI.0584-15.2015","volume":"35","author":"W-J Lin","year":"2015","unstructured":"Lin W-J, Jiang C, Sadahiro M, Bozdagi O, Vulchanova L, Alberini CM, Salton SR (2015) VGF and its C-terminal peptide TLQP-62 regulate memory formation in hippocampus via a BDNF-TrkB-dependent mechanism. J Neurosci 35(28):10343\u201310356","journal-title":"J Neurosci"},{"key":"5901_CR34","doi-asserted-by":"publisher","DOI":"10.2174\/0115672050380899250602042028","author":"D Kumar","year":"2025","unstructured":"Kumar D, Anand P, Singh SK (2025) Proposed therapeutic strategy to combat Alzheimer\u2019s disease by targeting beta and gamma secretases. Curr Alzheimer Res. https:\/\/doi.org\/10.2174\/0115672050380899250602042028","journal-title":"Curr Alzheimer Res"},{"key":"5901_CR35","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.jconrel.2016.06.001","volume":"235","author":"C-Y Lin","year":"2016","unstructured":"Lin C-Y, Perche F, Ikegami M, Uchida S, Kataoka K, Itaka K (2016) Messenger RNA-based therapeutics for brain diseases: an animal study for augmenting clearance of beta-amyloid by intracerebral administration of neprilysin mRNA loaded in polyplex nanomicelles. J Control Release 235:268\u2013275","journal-title":"J Control Release"},{"key":"5901_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2023.114968","volume":"199","author":"MI Sajid","year":"2023","unstructured":"Sajid MI, Sheikh FS, Anis F, Nasim N, Sumbria RK, Nauli SM, Tiwari RK (2023) siRNA drug delivery across the blood\u2013brain barrier in Alzheimer\u2019s disease. Adv Drug Deliv Rev 199:114968","journal-title":"Adv Drug Deliv Rev"},{"issue":"1","key":"5901_CR37","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1021\/acsami.1c15305","volume":"14","author":"S Gupta","year":"2021","unstructured":"Gupta S, Singh V, Ganesh S, Singhal NK, Sandhir R (2021) siRNA mediated GSK3\u03b2 knockdown targets insulin signaling pathway and rescues Alzheimer\u2019s disease pathology: evidence from in vitro and in vivo studies. ACS Appl Mater Interfaces 14(1):69\u201393","journal-title":"ACS Appl Mater Interfaces"},{"issue":"7","key":"5901_CR38","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/nrg3965","volume":"16","author":"S Jonas","year":"2015","unstructured":"Jonas S, Izaurralde E (2015) Towards a molecular understanding of microRNA-mediated gene silencing. Nat Rev Genet 16(7):421\u2013433","journal-title":"Nat Rev Genet"},{"issue":"2","key":"5901_CR39","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1002\/ana.23588","volume":"72","author":"ST Lee","year":"2012","unstructured":"Lee ST, Chu K, Jung KH, Kim JH, Huh JY, Yoon H, Park DK, Lim JY et al (2012) miR\u2010206 regulates brain\u2010derived neurotrophic factor in Alzheimer disease model. Ann Neurol 72(2):269\u2013277","journal-title":"Ann Neurol"},{"issue":"8","key":"5901_CR40","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1038\/mt.2013.118","volume":"21","author":"SR Murphy","year":"2013","unstructured":"Murphy SR, Chang CC, Dogbevia G, Bryleva EY, Bowen Z, Hasan MT, Chang T-Y (2013) Acat1 knockdown gene therapy decreases amyloid-\u03b2 in a mouse model of Alzheimer\u2019s disease. Mol Ther 21(8):1497\u20131506","journal-title":"Mol Ther"},{"key":"5901_CR41","doi-asserted-by":"publisher","first-page":"4329","DOI":"10.1007\/s12035-016-0002-4","volume":"54","author":"S Moncini","year":"2017","unstructured":"Moncini S, Lunghi M, Valmadre A, Grasso M, Del Vescovo V, Riva P, Denti MA, Venturin M (2017) The miR-15\/107 family of microRNA genes regulates CDK5R1\/p35 with implications for Alzheimer\u2019s disease pathogenesis. Mol Neurobiol 54:4329\u20134342","journal-title":"Mol Neurobiol"},{"key":"5901_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.110853","volume":"132","author":"A Safa","year":"2020","unstructured":"Safa A, Abak A, Shoorei H, Taheri M, Ghafouri-Fard S (2020) MicroRNAs as regulators of ERK\/MAPK pathway: a comprehensive review. Biomed Pharmacother 132:110853","journal-title":"Biomed Pharmacother"},{"key":"5901_CR43","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s00424-008-0618-y","volume":"458","author":"Y Tai","year":"2009","unstructured":"Tai Y, Feng S, Du W, Wang Y (2009) Functional roles of TRPC channels in the developing brain. Pflugers Arch Eur J Physiol 458:283\u2013289","journal-title":"Pflugers Arch Eur J Physiol"},{"key":"5901_CR44","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.688655","volume":"9","author":"R Xie","year":"2021","unstructured":"Xie R, Wang Z, Liu T, Xiao R, Lv K, Wu C, Luo Y, Cai Y, et al. (2021) AAV delivery of shRNA against TRPC6 in mouse hippocampus impairs cognitive function. Front Cell Dev Biol 9:688655","journal-title":"Front Cell Dev Biol"},{"key":"5901_CR45","doi-asserted-by":"crossref","unstructured":"Chakkyarath V (2025) Applications of advanced ASOs, RNA mimics, and others in RNA-based therapeutics. In: RNA-based cancer therapeutics: techniques, applications and challenges in prognosis. Springer, pp 35\u201362","DOI":"10.1007\/978-981-96-3456-9_3"},{"issue":"10","key":"5901_CR46","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1038\/nrneurol.2015.170","volume":"11","author":"H Malkki","year":"2015","unstructured":"Malkki H (2015) NGF gene therapy activates neurons in the AD patient brain. Nat Rev Neurol 11(10):548\u2013548. https:\/\/doi.org\/10.1038\/nrneurol.2015.170","journal-title":"Nat Rev Neurol"},{"issue":"12","key":"5901_CR47","doi-asserted-by":"publisher","first-page":"4303","DOI":"10.1016\/j.ymthe.2024.11.003","volume":"32","author":"C G\u00fcnaydin","year":"2024","unstructured":"G\u00fcnaydin C, Sondhi D, Kaminsky SM, Lephart HC, Leopold PL, Hackett NR, Khanna R, Crystal RG (2024) AAVrh.10 delivery of novel APOE2-Christchurch variant suppresses amyloid and tau pathology in Alzheimer\u2019s disease mice. Mol Ther 32(12):4303\u20134318. https:\/\/doi.org\/10.1016\/j.ymthe.2024.11.003","journal-title":"Mol Ther"},{"issue":"2","key":"5901_CR48","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.cell.2019.09.001","volume":"179","author":"JM Long","year":"2019","unstructured":"Long JM, Holtzman DM (2019) Alzheimer disease: an update on pathobiology and treatment strategies. Cell 179(2):312\u2013339","journal-title":"Cell"},{"issue":"1","key":"5901_CR49","doi-asserted-by":"publisher","first-page":"157","DOI":"10.3390\/antiox11010157","volume":"11","author":"AL Parsons","year":"2022","unstructured":"Parsons AL, Bucknor EM, Castroflorio E, Soares TR, Oliver PL, Rial D (2022) The interconnected mechanisms of oxidative stress and neuroinflammation in epilepsy. Antioxidants Basel 11(1):157","journal-title":"Antioxidants Basel"},{"issue":"1","key":"5901_CR50","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s13195-017-0283-5","volume":"9","author":"PS Aisen","year":"2017","unstructured":"Aisen PS, Cummings J, Jack CR Jr, Morris JC, Sperling R, Fr\u00f6lich L, Jones RW, Dowsett SA, et al. (2017) On the path to 2025: understanding the Alzheimer\u2019s disease continuum. Alzheimers Res Ther 9(1):60","journal-title":"Alzheimers Res Ther"},{"issue":"5","key":"5901_CR51","doi-asserted-by":"publisher","first-page":"1942","DOI":"10.1073\/pnas.0904532106","volume":"107","author":"RP Friedrich","year":"2010","unstructured":"Friedrich RP, Tepper K, R\u00f6nicke R, Soom M, Westermann M, Reymann K, Kaether C, F\u00e4ndrich M (2010) Mechanism of amyloid plaque formation suggests an intracellular basis of A\u03b2 pathogenicity. Proc Natl Acad Sci U S A 107(5):1942\u20131947","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"13","key":"5901_CR52","doi-asserted-by":"publisher","first-page":"4913","DOI":"10.1073\/pnas.83.13.4913","volume":"83","author":"I Grundke-Iqbal","year":"1986","unstructured":"Grundke-Iqbal I, Iqbal K, Tung Y-C, Quinlan M, Wisniewski HM, Binder LI (1986) Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology. Proc Natl Acad Sci U S A 83(13):4913\u20134917","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"5901_CR53","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","volume":"14","author":"MT Heneka","year":"2015","unstructured":"Heneka MT, Carson MJ, El Khoury J, Landreth GE, Brosseron F, Feinstein DL, Jacobs AH, Wyss-Coray T et al (2015) Neuroinflammation in Alzheimer\u2019s disease. Lancet Neurol 14(4):388\u2013405","journal-title":"Lancet Neurol"},{"issue":"6","key":"5901_CR54","doi-asserted-by":"publisher","first-page":"263","DOI":"10.5483\/BMBRep.2024-0044","volume":"57","author":"D Im","year":"2024","unstructured":"Im D, Choi TS (2024) Distinctive contribution of two additional residues in protein aggregation of A\u03b242 and A\u03b240 isoforms. BMB Rep 57(6):263","journal-title":"BMB Rep"},{"issue":"4","key":"5901_CR55","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1056\/NEJMra0909142","volume":"362","author":"HW Querfurth","year":"2010","unstructured":"Querfurth HW, LaFerla FM (2010) Alzheimer\u2019s disease. N Engl J Med 362(4):329\u2013344","journal-title":"N Engl J Med"},{"key":"5901_CR56","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2021.752594","volume":"15","author":"R Sanchez-Varo","year":"2021","unstructured":"Sanchez-Varo R, Sanchez-Mejias E, Fernandez-Valenzuela JJ, De Castro V, Mejias-Ortega M, Gomez-Arboledas A, Jimenez S, Sanchez-Mico MV et al (2021) Plaque-associated oligomeric amyloid-beta drives early synaptotoxicity in APP\/PS1 mice hippocampus: ultrastructural pathology analysis. Front Neurosci 15:752594","journal-title":"Front Neurosci"},{"issue":"6","key":"5901_CR57","doi-asserted-by":"publisher","first-page":"595","DOI":"10.15252\/emmm.201606210","volume":"8","author":"DJ Selkoe","year":"2016","unstructured":"Selkoe DJ, Hardy J (2016) The amyloid hypothesis of Alzheimer\u2019s disease at 25 years. EMBO Mol Med 8(6):595\u2013608","journal-title":"EMBO Mol Med"},{"issue":"11","key":"5901_CR58","doi-asserted-by":"publisher","first-page":"2915","DOI":"10.1111\/ejn.16336","volume":"59","author":"T Ahmed","year":"2024","unstructured":"Ahmed T (2024) Lipid nanoparticle mediated small interfering RNA delivery as a potential therapy for Alzheimer\u2019s disease. Eur J Neurosci 59(11):2915\u20132954","journal-title":"Eur J Neurosci"},{"issue":"4","key":"5901_CR59","first-page":"235","volume":"19","author":"MR Wilson","year":"2023","unstructured":"Wilson MR, Satapathy S, Vendruscolo M (2023) Extracellular protein homeostasis in neurodegenerative diseases. Nat Rev Neurol 19(4):235\u2013245","journal-title":"Nat Rev Neurol"},{"issue":"8","key":"5901_CR60","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202309225","volume":"36","author":"WT Ralvenius","year":"2024","unstructured":"Ralvenius WT, Andresen JL, Huston MM, Penney J, Bonner JM, Fenton OS, Langer R, Tsai LH (2024) Nanoparticle-mediated delivery of anti-PU.1 siRNA via localized intracisternal administration reduces neuroinflammation. Adv Mater 36(8):e2309225. https:\/\/doi.org\/10.1002\/adma.202309225","journal-title":"Adv Mater"},{"issue":"2","key":"5901_CR61","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1021\/nn504905q","volume":"9","author":"A Mangraviti","year":"2015","unstructured":"Mangraviti A, Tzeng SY, Kozielski KL, Wang Y, Jin Y, Gullotti D, Pedone M, Buaron N, et al. (2015) Polymeric nanoparticles for nonviral gene therapy extend brain tumor survival in vivo. ACS Nano 9(2):1236\u20131249","journal-title":"ACS Nano"},{"issue":"4","key":"5901_CR62","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/nbt.1807","volume":"29","author":"L Alvarez-Erviti","year":"2011","unstructured":"Alvarez-Erviti L, Seow Y, Yin H, Betts C, Lakhal S, Wood MJ (2011) Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat Biotechnol 29(4):341\u2013345","journal-title":"Nat Biotechnol"},{"issue":"9","key":"5901_CR63","doi-asserted-by":"publisher","first-page":"648","DOI":"10.2174\/1871527319999200819095620","volume":"19","author":"M Pandey","year":"2020","unstructured":"Pandey M, Choudhury H, Verma RK, Chawla V, Bhattamisra SK, Gorain B, Raja MA, Amjad MW (2020) Nanoparticles based intranasal delivery of drug to treat Alzheimer\u2019s disease: a recent update. CNS Neurol Disord Drug Targets 19(9):648\u2013662","journal-title":"CNS Neurol Disord Drug Targets"},{"issue":"2","key":"5901_CR64","doi-asserted-by":"publisher","first-page":"89","DOI":"10.3390\/cells14020089","volume":"14","author":"EH Ahn","year":"2025","unstructured":"Ahn EH, Park J-B (2025) Molecular mechanisms of Alzheimer\u2019s disease induced by amyloid-\u03b2 and tau phosphorylation along with rhoa activity: perspective of rhoa\/Rho-associated protein kinase inhibitors for neuronal therapy. Cells 14(2):89","journal-title":"Cells"},{"issue":"07","key":"5901_CR65","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1055\/a-2238-1384","volume":"56","author":"A Singh","year":"2024","unstructured":"Singh A, Ansari VA, Mahmood T, Hasan SM, Wasim R, Maheshwari S, Akhtar J, Sheikh S et al (2024) Targeting abnormal tau phosphorylation for Alzheimer\u2019s therapeutics. Horm Metab Res 56(07):482\u2013488","journal-title":"Horm Metab Res"},{"issue":"8","key":"5901_CR66","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.2967\/jnumed.122.265200","volume":"64","author":"AC Macedo","year":"2023","unstructured":"Macedo AC, Tissot C, Therriault J, Servaes S, Wang Y-T, Fernandez-Arias J, Rahmouni N, Lussier FZ et al (2023) The use of tau PET to stage Alzheimer disease according to the Braak staging framework. J Nucl Med 64(8):1171\u20131178","journal-title":"J Nucl Med"},{"issue":"1","key":"5901_CR67","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-04529-6","volume":"9","author":"N Lipsman","year":"2018","unstructured":"Lipsman N, Meng Y, Bethune AJ, Huang Y, Lam B, Masellis M, Herrmann N, Heyn C et al (2018) Blood-brain barrier opening in Alzheimer\u2019s disease using MR-guided focused ultrasound. Nat Commun 9(1):2336. https:\/\/doi.org\/10.1038\/s41467-018-04529-6","journal-title":"Nat Commun"},{"issue":"aop","key":"5901_CR68","first-page":"1","volume":"1","author":"BS Ye","year":"2025","unstructured":"Ye BS, Chang KW, Kang S, Jeon S, Chang JW (2025) Repetitive and extensive focused ultrasound\u2013mediated bilateral frontal blood-brain barrier opening for Alzheimer\u2019s disease. J Neurosurg 1(aop):1\u20138","journal-title":"J Neurosurg"},{"issue":"3","key":"5901_CR69","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1159\/000363623","volume":"14","author":"T Spirig","year":"2014","unstructured":"Spirig T, Ovchinnikova O, Vagt T, Glockshuber R (2014) Direct evidence for self-propagation of different amyloid-\u03b2 fibril conformations. Neurodegener Dis 14(3):151\u2013159","journal-title":"Neurodegener Dis"},{"key":"5901_CR70","doi-asserted-by":"publisher","unstructured":"Jack CR Jr., Bennett DA, Blennow K, Carrillo MC, Dunn B, Haeberlein SB, Holtzman DM, Jagust W et al (2018) NIA-AA research framework: toward a biological definition of Alzheimer\u2019s disease. Alzheimers Dement 14(4):535\u2013562. https:\/\/doi.org\/10.1016\/j.jalz.2018.02.018","DOI":"10.1016\/j.jalz.2018.02.018"},{"issue":"2","key":"5901_CR71","doi-asserted-by":"publisher","first-page":"331","DOI":"10.3390\/jcm14020331","volume":"14","author":"C Long","year":"2025","unstructured":"Long C, Fritts A, Broadway J, Brawman-Mintzer O, Mintzer J (2025) Neuroinflammation: a driving force in the onset and progression of Alzheimer\u2019s disease. J Clin Med 14(2):331","journal-title":"J Clin Med"},{"issue":"11","key":"5901_CR72","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1001\/jamaneurol.2023.3530","volume":"80","author":"RN Taddei","year":"2023","unstructured":"Taddei RN, Perbet R, Mate de Gerando A, Wiedmer AE, Sanchez-Mico M, Connors Stewart T, Gaona A, Melloni A et al (2023) Tau oligomer\u2013containing synapse elimination by microglia and astrocytes in Alzheimer disease. JAMA Neurol 80(11):1209\u20131221","journal-title":"JAMA Neurol"},{"issue":"10","key":"5901_CR73","first-page":"136","volume":"3","author":"W-Y Wang","year":"2015","unstructured":"Wang W-Y, Tan M-S, Yu J-T, Tan L (2015) Role of pro-inflammatory cytokines released from microglia in Alzheimer\u2019s disease. Ann Transl Med 3(10):136","journal-title":"Ann Transl Med"},{"issue":"4","key":"5901_CR74","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1001\/jamaneurol.2013.5847","volume":"71","author":"GS Bloom","year":"2014","unstructured":"Bloom GS (2014) Amyloid-\u03b2 and tau: the trigger and bullet in Alzheimer disease pathogenesis. JAMA Neurol 71(4):505\u2013508","journal-title":"JAMA Neurol"},{"issue":"4","key":"5901_CR75","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1016\/j.neuron.2014.05.004","volume":"82","author":"TL Spires-Jones","year":"2014","unstructured":"Spires-Jones TL, Hyman BT (2014) The intersection of amyloid beta and tau at synapses in Alzheimer\u2019s disease. Neuron 82(4):756\u2013771","journal-title":"Neuron"},{"key":"5901_CR76","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.trci.2018.06.014","volume":"4","author":"JW Kinney","year":"2018","unstructured":"Kinney JW, Bemiller SM, Murtishaw AS, Leisgang AM, Salazar AM, Lamb BT (2018) Inflammation as a central mechanism in Alzheimer\u2019s disease. Alzheimers Dement Transl Res Clin Interv 4:575\u2013590","journal-title":"Alzheimers Dement Transl Res Clin Interv"},{"issue":"10","key":"5901_CR77","doi-asserted-by":"publisher","first-page":"851","DOI":"10.52586\/4992","volume":"26","author":"M Faiyaz","year":"2021","unstructured":"Faiyaz M, Ganayee MA, Akhtar S, Krishnan S, Flora B, Dogra D, Jha NK, Chellappan DK et al (2021) Nanomaterials in Alzheimer\u2019s disease treatment: a comprehensive review. Front Biosci (Landmark Ed) 26(10):851\u2013865. https:\/\/doi.org\/10.52586\/4992","journal-title":"Front Biosci (Landmark Ed)"},{"key":"5901_CR78","doi-asserted-by":"publisher","unstructured":"Jones RE, Andrews R, Holmans P, Hill M, Taylor PR (2021) Modest changes in Spi1 dosage reveal the potential for altered microglial function as seen in Alzheimer\u2019s disease. Sci Rep 11(1):14935. https:\/\/doi.org\/10.1038\/s41598-021-94324-z","DOI":"10.1038\/s41598-021-94324-z"},{"issue":"12","key":"5901_CR79","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.2174\/1389450122999210104205018","volume":"22","author":"I Kaur","year":"2021","unstructured":"Kaur I, Kumar A, Behl T, Setia D (2021) Recent advances in nanotechnology-based drug delivery approaches for Alzheimer disease. Curr Drug Targets 22(12):1404\u20131423","journal-title":"Curr Drug Targets"},{"issue":"3","key":"5901_CR80","doi-asserted-by":"publisher","first-page":"986","DOI":"10.3390\/nu13030986","volume":"13","author":"V Sambra","year":"2021","unstructured":"Sambra V, Echeverria F, Valenzuela A, Chouinard-Watkins R, Valenzuela R (2021) Docosahexaenoic and arachidonic acids as neuroprotective nutrients throughout the life cycle. Nutrients 13(3):986","journal-title":"Nutrients"},{"key":"5901_CR81","doi-asserted-by":"publisher","unstructured":"Behroozi Z, Askarpour H, Baghcheghi Y (2026) Molecular sabotage of hippocampal synaptic plasticity by amyloid-\u03b2 in Alzheimer\u2019s disease: A narrative review. J Alzheimers Dis Rep 10:25424823261415807. https:\/\/doi.org\/10.1177\/25424823261415807","DOI":"10.1177\/25424823261415807"},{"issue":"20","key":"5901_CR82","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21207452","volume":"21","author":"VN Bukke","year":"2020","unstructured":"Bukke VN, Archana M, Villani R, Romano AD, Wawrzyniak A, Balawender K, Orkisz S, Beggiato S et al (2020) The dual role of glutamatergic neurotransmission in Alzheimer\u2019s disease: from pathophysiology to pharmacotherapy. Int J Mol Sci 21(20):7452","journal-title":"Int J Mol Sci"},{"issue":"1","key":"5901_CR83","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.jalz.2018.08.005","volume":"15","author":"DP Veitch","year":"2019","unstructured":"Veitch DP, Weiner MW, Aisen PS, Beckett LA, Cairns NJ, Green RC, Harvey D, Jack CR Jr, et al. (2019) Understanding disease progression and improving Alzheimer\u2019s disease clinical trials: recent highlights from the Alzheimer\u2019s disease neuroimaging initiative. Alzheimers Dement 15(1):106\u2013152","journal-title":"Alzheimers Dement"},{"issue":"5","key":"5901_CR84","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1038\/nm1239","volume":"11","author":"MH Tuszynski","year":"2005","unstructured":"Tuszynski MH, Thal L, Pay M, Salmon DP, U HS, Bakay R, Patel P, Blesch A et al (2005) A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease. Nat Med 11(5):551\u2013555","journal-title":"Nat Med"},{"key":"5901_CR85","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2025.1629796","volume":"19","author":"Y Liu","year":"2025","unstructured":"Liu Y, Zhang G, Qi R, Ma J, Xu J (2025) State-dependent memory mechanisms insights from neural circuits and clinical implications. Front Cell Neurosci 19:1629796","journal-title":"Front Cell Neurosci"},{"issue":"7","key":"5901_CR86","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1001\/jamaneurol.2018.0233","volume":"75","author":"MS Rafii","year":"2018","unstructured":"Rafii MS, Tuszynski MH, Thomas RG, Barba D, Brewer JB, Rissman RA, Siffert J, Aisen PS (2018) Adeno-associated viral vector (serotype 2)-nerve growth factor for patients with Alzheimer disease: a randomized clinical trial. JAMA Neurol 75(7):834\u2013841. https:\/\/doi.org\/10.1001\/jamaneurol.2018.0233","journal-title":"JAMA Neurol"},{"issue":"5","key":"5901_CR87","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/alzrt211","volume":"5","author":"X Zhang","year":"2013","unstructured":"Zhang X, Song W (2013) The role of APP and BACE1 trafficking in APP processing and amyloid-\u03b2 generation. Alzheimers Res Ther 5(5):46","journal-title":"Alzheimers Res Ther"},{"issue":"1","key":"5901_CR88","doi-asserted-by":"publisher","first-page":"30","DOI":"10.52243\/bptjm.v1i2.22","volume":"2","author":"H Bhagwat","year":"2022","unstructured":"Bhagwat H, Bronstein S, Bhatt A, Nguyen V (2022) Neurogenesis: gene-based strategies for treating ischemic stroke. Berkeley Pharma Tech Journal of Medicine 2(1):30\u201357","journal-title":"Berkeley Pharma Tech Journal of Medicine"},{"issue":"9","key":"5901_CR89","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1007\/s00018-019-03349-1","volume":"77","author":"CA Brunello","year":"2020","unstructured":"Brunello CA, Merezhko M, Uronen R-L, Huttunen HJ (2020) Mechanisms of secretion and spreading of pathological tau protein. Cell Mol Life Sci 77(9):1721\u20131744","journal-title":"Cell Mol Life Sci"},{"issue":"10","key":"5901_CR90","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1586\/ern.09.99","volume":"9","author":"W Debinski","year":"2009","unstructured":"Debinski W, Tatter SB (2009) Convection-enhanced delivery for the treatment of brain tumors. Expert Rev Neurother 9(10):1519\u20131527. https:\/\/doi.org\/10.1586\/ern.09.99","journal-title":"Expert Rev Neurother"},{"issue":"278","key":"5901_CR91","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaa2512","volume":"7","author":"G Leinenga","year":"2015","unstructured":"Leinenga G, G\u00f6tz J (2015) Scanning ultrasound removes amyloid-\u03b2 and restores memory in an Alzheimer\u2019s disease mouse model. Sci Transl Med 7(278):278ra233-278ra233","journal-title":"Sci Transl Med"},{"issue":"2","key":"5901_CR92","doi-asserted-by":"publisher","first-page":"444","DOI":"10.3390\/pharmaceutics14020444","volume":"14","author":"C-Y Lin","year":"2022","unstructured":"Lin C-Y, Huang C-Y, Chen C-M, Liu H-L (2022) Focused ultrasound-induced blood\u2013brain barrier opening enhanced \u03b1-synuclein expression in mice for modeling Parkinson\u2019s disease. Pharmaceutics 14(2):444","journal-title":"Pharmaceutics"},{"issue":"1","key":"5901_CR93","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1080\/1061186X.2021.1927055","volume":"30","author":"Q Ouyang","year":"2022","unstructured":"Ouyang Q, Meng Y, Zhou W, Tong J, Cheng Z, Zhu Q (2022) New advances in brain-targeting nano-drug delivery systems for Alzheimer\u2019s disease. J Drug Target 30(1):61\u201381","journal-title":"J Drug Target"},{"issue":"3","key":"5901_CR94","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.cherd.2008.09.010","volume":"87","author":"Y Han","year":"2009","unstructured":"Han Y, Liu S, Ho J, Danquah MK, Forde GM (2009) Using DNA as a drug\u2014bioprocessing and delivery strategies. Chem Eng Res Des 87(3):343\u2013348","journal-title":"Chem Eng Res Des"},{"issue":"11","key":"5901_CR95","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14112296","volume":"14","author":"D Nunes","year":"2022","unstructured":"Nunes D, Loureiro JA, Pereira MC (2022) Drug delivery systems as a strategy to improve the efficacy of FDA-approved Alzheimer\u2019s drugs. Pharmaceutics 14(11):2296","journal-title":"Pharmaceutics"},{"issue":"7","key":"5901_CR96","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.tips.2020.04.008","volume":"41","author":"O Benek","year":"2020","unstructured":"Benek O, Korabecny J, Soukup O (2020) A perspective on multi-target drugs for Alzheimer\u2019s disease. Trends Pharmacol Sci 41(7):434\u2013445","journal-title":"Trends Pharmacol Sci"},{"issue":"1","key":"5901_CR97","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-022-01007-w","volume":"7","author":"S Qin","year":"2022","unstructured":"Qin S, Tang X, Chen Y, Chen K, Fan N, Xiao W, Zheng Q, Li G et al (2022) mRNA-based therapeutics: powerful and versatile tools to combat diseases. Signal Transduct Target Ther 7(1):166. https:\/\/doi.org\/10.1038\/s41392-022-01007-w","journal-title":"Signal Transduct Target Ther"},{"issue":"8","key":"5901_CR98","doi-asserted-by":"publisher","first-page":"2306","DOI":"10.1016\/j.apsb.2020.11.023","volume":"11","author":"L Han","year":"2021","unstructured":"Han L, Jiang C (2021) Evolution of blood\u2013brain barrier in brain diseases and related systemic nanoscale brain-targeting drug delivery strategies. Acta Pharm Sin B 11(8):2306\u20132325","journal-title":"Acta Pharm Sin B"},{"key":"5901_CR99","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/j.biopha.2018.12.133","volume":"111","author":"M Saeedi","year":"2019","unstructured":"Saeedi M, Eslamifar M, Khezri K, Dizaj SM (2019) Applications of nanotechnology in drug delivery to the central nervous system. Biomed Pharmacother 111:666\u2013675","journal-title":"Biomed Pharmacother"},{"issue":"12","key":"5901_CR100","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1038\/s41578-021-00358-0","volume":"6","author":"X Hou","year":"2021","unstructured":"Hou X, Zaks T, Langer R, Dong Y (2021) Lipid nanoparticles for mRNA delivery. Nat Rev Mater 6(12):1078\u20131094. https:\/\/doi.org\/10.1038\/s41578-021-00358-0","journal-title":"Nat Rev Mater"},{"key":"5901_CR101","doi-asserted-by":"publisher","unstructured":"Kaur N, Kumar V, Mahender T, Maji I, Mahajan S, Aalhate M, Singh PK, Sahu SK (2022)\u00a0Chapter 5 -\u00a0Nanomedical drug delivery for neurodegenerative disease. In: Nanomedical Drug Delivery for Neurodegenerative Diseases. Academic Press, pp 67\u201379. https:\/\/doi.org\/10.1016\/B978-0-323-85544-0.00016-2","DOI":"10.1016\/B978-0-323-85544-0.00016-2"},{"issue":"22","key":"5901_CR102","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232213954","volume":"23","author":"E Passeri","year":"2022","unstructured":"Passeri E, Elkhoury K, Morsink M, Broersen K, Linder M, Tamayol A, Malaplate C, Yen FT et al (2022) Alzheimer\u2019s disease: treatment strategies and their limitations. Int J Mol Sci 23(22):13954","journal-title":"Int J Mol Sci"},{"issue":"1","key":"5901_CR103","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s41392-019-0068-3","volume":"4","author":"AP Singh","year":"2019","unstructured":"Singh AP, Biswas A, Shukla A, Maiti P (2019) Targeted therapy in chronic diseases using nanomaterial-based drug delivery vehicles. Signal Transduct Target Ther 4(1):33","journal-title":"Signal Transduct Target Ther"},{"issue":"8","key":"5901_CR104","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13081183","volume":"13","author":"MK Satapathy","year":"2021","unstructured":"Satapathy MK, Yen T-L, Jan J-S, Tang R-D, Wang J-Y, Taliyan R, Yang C-H (2021) Solid lipid nanoparticles (SLNs): an advanced drug delivery system targeting brain through BBB. Pharmaceutics 13(8):1183","journal-title":"Pharmaceutics"},{"issue":"6","key":"5901_CR105","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.7150\/thno.21254","volume":"8","author":"X Dong","year":"2018","unstructured":"Dong X (2018) Current strategies for brain drug delivery. Theranostics 8(6):1481","journal-title":"Theranostics"},{"issue":"43","key":"5901_CR106","doi-asserted-by":"publisher","DOI":"10.1002\/smll.201701921","volume":"13","author":"YH Tsou","year":"2017","unstructured":"Tsou YH, Zhang XQ, Zhu H, Syed S, Xu X (2017) Drug delivery to the brain across the blood\u2013brain barrier using nanomaterials. Small 13(43):1701921","journal-title":"Small"},{"key":"5901_CR107","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S200490","author":"S Tiwari","year":"2019","unstructured":"Tiwari S, Atluri V, Kaushik A, Yndart A, Nair M (2019) Alzheimer\u2019s disease: pathogenesis, diagnostics, and therapeutics. Int J Nanomedicine. https:\/\/doi.org\/10.2147\/IJN.S200490","journal-title":"Int J Nanomedicine"},{"issue":"1","key":"5901_CR108","doi-asserted-by":"publisher","DOI":"10.1002\/trc2.12050","volume":"6","author":"J Cummings","year":"2020","unstructured":"Cummings J, Lee G, Ritter A, Sabbagh M, Zhong K (2020) Alzheimer\u2019s disease drug development pipeline: 2020. Alzheimers Dement N Y 6(1):e12050","journal-title":"Alzheimers Dement N Y"},{"key":"5901_CR109","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.jconrel.2016.05.044","volume":"235","author":"C Saraiva","year":"2016","unstructured":"Saraiva C, Pra\u00e7a C, Ferreira R, Santos T, Ferreira L, Bernardino L (2016) Nanoparticle-mediated brain drug delivery: overcoming blood-brain barrier to treat neurodegenerative diseases. J Control Release 235:34\u201347. https:\/\/doi.org\/10.1016\/j.jconrel.2016.05.044","journal-title":"J Control Release"},{"issue":"1","key":"5901_CR110","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-025-03109-3","volume":"23","author":"YJ Jang","year":"2025","unstructured":"Jang YJ, Kang SJ, Park HS, Lee DH, Kim JH, Kim JE, Kim DI, Chung CH et al (2025) Drug delivery strategies with lipid-based nanoparticles for Alzheimer\u2019s disease treatment. J Nanobiotechnology 23(1):99. https:\/\/doi.org\/10.1186\/s12951-025-03109-3","journal-title":"J Nanobiotechnology"},{"issue":"7","key":"5901_CR111","doi-asserted-by":"publisher","first-page":"3183","DOI":"10.7150\/thno.52570","volume":"11","author":"Y Liang","year":"2021","unstructured":"Liang Y, Duan L, Lu J, Xia J (2021) Engineering exosomes for targeted drug delivery. Theranostics 11(7):3183","journal-title":"Theranostics"},{"issue":"1","key":"5901_CR112","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s13195-019-0529-5","volume":"11","author":"J Cummings","year":"2019","unstructured":"Cummings J, Feldman HH, Scheltens P (2019) The \u201crights\u201d of precision drug development for Alzheimer\u2019s disease. Alzheimers Res Ther 11(1):76","journal-title":"Alzheimers Res Ther"},{"issue":"4","key":"5901_CR113","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.12787","volume":"53","author":"X Shao","year":"2020","unstructured":"Shao X, Cui W, Xie X, Ma W, Zhan Y, Lin Y (2020) Treatment of Alzheimer\u2019s disease with framework nucleic acids. Cell Prolif 53(4):e12787","journal-title":"Cell Prolif"},{"key":"5901_CR114","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.biomaterials.2015.11.060","volume":"80","author":"Y Liu","year":"2016","unstructured":"Liu Y, An S, Li J, Kuang Y, He X, Guo Y, Ma H, Zhang Y et al (2016) Brain-targeted co-delivery of therapeutic gene and peptide by multifunctional nanoparticles in Alzheimer\u2019s disease mice. Biomaterials 80:33\u201345","journal-title":"Biomaterials"},{"key":"5901_CR115","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.colsurfb.2017.01.031","volume":"152","author":"G Rassu","year":"2017","unstructured":"Rassu G, Soddu E, Posadino AM, Pintus G, Sarmento B, Giunchedi P, Gavini E (2017) Nose-to-brain delivery of BACE1 siRNA loaded in solid lipid nanoparticles for Alzheimer\u2019s therapy. Colloids Surf B Biointerfaces 152:296\u2013301","journal-title":"Colloids Surf B Biointerfaces"},{"issue":"7","key":"5901_CR116","doi-asserted-by":"publisher","DOI":"10.3390\/bioengineering12070707","volume":"12","author":"L De Waele","year":"2025","unstructured":"De Waele L, Di Pietro M, Perilli S, Mantini E, Trevisan G, Simoncini M, Panella M, Betti V et al (2025) Aerosol jet printing for neuroprosthetic device development. Bioengineering 12(7):0707. https:\/\/doi.org\/10.3390\/bioengineering12070707","journal-title":"Bioengineering"},{"key":"5901_CR117","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.csbj.2024.05.018","volume":"25","author":"FR Cassee","year":"2024","unstructured":"Cassee FR, Bleeker EAJ, Durand C, Exner T, Falk A, Friedrichs S, Heunisch E, Himly M et al (2024) Roadmap towards safe and sustainable advanced and innovative materials. (Outlook for 2024-2030). Comput Struct Biotechnol J 25:105\u2013126. https:\/\/doi.org\/10.1016\/j.csbj.2024.05.018","journal-title":"Comput Struct Biotechnol J"},{"issue":"29","key":"5901_CR118","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202314354","volume":"36","author":"Y Liu","year":"2024","unstructured":"Liu Y, Xia X, Zheng M, Shi B (2024) Bio-nano toolbox for precision Alzheimer\u2019s disease gene therapy. Adv Mater 36(29):e2314354. https:\/\/doi.org\/10.1002\/adma.202314354","journal-title":"Adv Mater"},{"issue":"7","key":"5901_CR119","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1016\/j.ymthe.2017.03.013","volume":"25","author":"PR Cullis","year":"2017","unstructured":"Cullis PR, Hope MJ (2017) Lipid nanoparticle systems for enabling gene therapies. Mol Ther 25(7):1467\u20131475. https:\/\/doi.org\/10.1016\/j.ymthe.2017.03.013","journal-title":"Mol Ther"},{"key":"5901_CR120","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.addr.2013.08.008","volume":"71","author":"J Kreuter","year":"2014","unstructured":"Kreuter J (2014) Drug delivery to the central nervous system by polymeric nanoparticles: what do we know? Adv Drug Deliv Rev 71:2\u201314. https:\/\/doi.org\/10.1016\/j.addr.2013.08.008","journal-title":"Adv Drug Deliv Rev"},{"key":"5901_CR121","doi-asserted-by":"publisher","DOI":"10.1126\/science.aau6977","author":"R Kalluri","year":"2020","unstructured":"Kalluri R, LeBleu VS (2020) The biology, function, and biomedical applications of exosomes. Science. https:\/\/doi.org\/10.1126\/science.aau6977","journal-title":"Science"},{"issue":"1","key":"5901_CR122","doi-asserted-by":"publisher","DOI":"10.1080\/20013078.2018.1535750","volume":"7","author":"C Th\u00e9ry","year":"2018","unstructured":"Th\u00e9ry C, Witwer KW, Aikawa E, Alcaraz MJ, Anderson JD, Andriantsitohaina R, Antoniou A, Arab T et al (2018) Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. J Extracell Vesicles 7(1):1535750. https:\/\/doi.org\/10.1080\/20013078.2018.1535750","journal-title":"J Extracell Vesicles"},{"key":"5901_CR123","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines12101148","author":"J Wang","year":"2024","unstructured":"Wang J, Ding Y, Chong K, Cui M, Cao Z, Tang C, Tian Z, Hu Y et al (2024) Recent advances in lipid nanoparticles and their safety concerns for mRNA delivery. Vaccines. https:\/\/doi.org\/10.3390\/vaccines12101148","journal-title":"Vaccines"},{"key":"5901_CR124","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbpa.2024.102499","volume":"81","author":"Y Zhao","year":"2024","unstructured":"Zhao Y, Wang ZM, Song D, Chen M, Xu Q (2024) Rational design of lipid nanoparticles: overcoming physiological barriers for selective intracellular mRNA delivery. Curr Opin Chem Biol 81:102499. https:\/\/doi.org\/10.1016\/j.cbpa.2024.102499","journal-title":"Curr Opin Chem Biol"},{"issue":"1","key":"5901_CR125","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s43586-022-00104-y","volume":"2","author":"BB Mendes","year":"2022","unstructured":"Mendes BB, Conniot J, Avital A, Yao D, Jiang X, Zhou X, Sharf-Pauker N, Xiao Y, et al. (2022) Nanodelivery of nucleic acids. Nat Rev Methods Primers 2(1):24","journal-title":"Nat Rev Methods Primers"},{"key":"5901_CR126","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2022.e09239","author":"TM Soelter","year":"2022","unstructured":"Soelter TM, Whitlock JH, Williams AS, Hardigan AA, Lasseigne BN (2022) Nucleic acid liquid biopsies in Alzheimer\u2019s disease: current state, challenges, and opportunities. Heliyon. https:\/\/doi.org\/10.1016\/j.heliyon.2022.e09239","journal-title":"Heliyon"},{"issue":"15","key":"5901_CR127","doi-asserted-by":"publisher","first-page":"4109","DOI":"10.1039\/D0BM00809E","volume":"8","author":"SM Asil","year":"2020","unstructured":"Asil SM, Ahlawat J, Barroso GG, Narayan M (2020) Nanomaterial based drug delivery systems for the treatment of neurodegenerative diseases. Biomater Sci 8(15):4109\u20134128","journal-title":"Biomater Sci"},{"issue":"1","key":"5901_CR128","doi-asserted-by":"publisher","first-page":"178","DOI":"10.3390\/pharmaceutics15010178","volume":"15","author":"Y Gao","year":"2023","unstructured":"Gao Y, Liu X, Chen N, Yang X, Tang F (2023) Recent advance of liposome nanoparticles for nucleic acid therapy. Pharmaceutics 15(1):178","journal-title":"Pharmaceutics"},{"issue":"1","key":"5901_CR129","doi-asserted-by":"publisher","DOI":"10.1186\/s43556-023-00160-0","volume":"4","author":"Y Qin","year":"2023","unstructured":"Qin Y, Ou L, Zha L, Zeng Y, Li L (2023) Delivery of nucleic acids using nanomaterials. Mol Biomed 4(1):48. https:\/\/doi.org\/10.1186\/s43556-023-00160-0","journal-title":"Mol Biomed"},{"issue":"3","key":"5901_CR130","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1111\/bcp.12987","volume":"82","author":"K Sridharan","year":"2016","unstructured":"Sridharan K, Gogtay NJ (2016) Therapeutic nucleic acids: current clinical status. Br J Clin Pharmacol 82(3):659\u2013672","journal-title":"Br J Clin Pharmacol"},{"key":"5901_CR131","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S117210","author":"DB Vieira","year":"2016","unstructured":"Vieira DB, Gamarra LF (2016) Getting into the brain: liposome-based strategies for effective drug delivery across the blood\u2013brain barrier. Int J Nanomedicine. https:\/\/doi.org\/10.2147\/IJN.S117210","journal-title":"Int J Nanomedicine"},{"issue":"18","key":"5901_CR132","doi-asserted-by":"publisher","first-page":"11527","DOI":"10.1021\/acs.chemrev.0c00997","volume":"121","author":"R Kumar","year":"2021","unstructured":"Kumar R, Santa Chalarca CF, Bockman MR, Bruggen CV, Grimme CJ, Dalal RJ, Hanson MG, Hexum JK et al (2021) Polymeric delivery of therapeutic nucleic acids. Chem Rev 121(18):11527\u201311652","journal-title":"Chem Rev"},{"issue":"1","key":"5901_CR133","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/s41392-023-01481-w","volume":"8","author":"D Wu","year":"2023","unstructured":"Wu D, Chen Q, Chen X, Han F, Chen Z, Wang Y (2023) The blood\u2013brain barrier: structure, regulation and drug delivery. Signal Transduct Target Ther 8(1):217","journal-title":"Signal Transduct Target Ther"},{"key":"5901_CR134","first-page":"726","volume":"17","author":"X Ren","year":"2019","unstructured":"Ren X, Zhao Y, Xue F, Zheng Y, Huang H, Wang W, Chang Y, Yang H et al (2019) Exosomal DNA aptamer targeting \u03b1-synuclein aggregates reduced neuropathological deficits in a mouse Parkinson\u2019s disease model. Mol Ther 17:726\u2013740","journal-title":"Mol Ther"},{"issue":"1","key":"5901_CR135","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1080\/10717544.2018.1428243","volume":"25","author":"G Karthivashan","year":"2018","unstructured":"Karthivashan G, Ganesan P, Park S-Y, Kim J-S, Choi D-K (2018) Therapeutic strategies and nano-drug delivery applications in management of ageing Alzheimer\u2019s disease. Drug Deliv 25(1):307\u2013320","journal-title":"Drug Deliv"},{"key":"5901_CR136","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3389\/fnmol.2016.00129","volume":"9","author":"MM Wen","year":"2016","unstructured":"Wen MM (2016) Getting miRNA therapeutics into the target cells for neurodegenerative diseases: a mini-review. Front Mol Neurosci 9:129","journal-title":"Front Mol Neurosci"},{"key":"5901_CR137","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.jconrel.2018.04.034","volume":"279","author":"P Wang","year":"2018","unstructured":"Wang P, Zheng X, Guo Q, Yang P, Pang X, Qian K, Lu W, Zhang Q et al (2018) Systemic delivery of BACE1 siRNA through neuron-targeted nanocomplexes for treatment of Alzheimer\u2019s disease. J Control Release 279:220\u2013233","journal-title":"J Control Release"},{"key":"5901_CR138","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.ijbiomac.2014.08.052","volume":"72","author":"J Sarvaiya","year":"2015","unstructured":"Sarvaiya J, Agrawal Y (2015) Chitosan as a suitable nanocarrier material for anti-Alzheimer drug delivery. Int J Biol Macromol 72:454\u2013465","journal-title":"Int J Biol Macromol"},{"issue":"41","key":"5901_CR139","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abc7031","volume":"6","author":"Y Zhou","year":"2020","unstructured":"Zhou Y, Zhu F, Liu Y, Zheng M, Wang Y, Zhang D, Anraku Y, Zou Y, et al. (2020) Blood-brain barrier\u2013penetrating siRNA nanomedicine for Alzheimer\u2019s disease therapy. Sci Adv 6(41):eabc7031","journal-title":"Sci Adv"},{"issue":"11","key":"5901_CR140","doi-asserted-by":"publisher","first-page":"17802","DOI":"10.1021\/acsnano.2c08774","volume":"16","author":"R Tenchov","year":"2022","unstructured":"Tenchov R, Sasso JM, Wang X, Liaw W-S, Chen C-A, Zhou QA (2022) Exosomes\u2500 nature\u2019s lipid nanoparticles, a rising star in drug delivery and diagnostics. ACS Nano 16(11):17802\u201317846","journal-title":"ACS Nano"},{"issue":"2","key":"5901_CR141","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.pharep.2014.09.004","volume":"67","author":"A Kumar","year":"2015","unstructured":"Kumar A, Singh A (2015) A review on Alzheimer\u2019s disease pathophysiology and its management: an update. Pharmacol Rep 67(2):195\u2013203","journal-title":"Pharmacol Rep"},{"key":"5901_CR142","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.jconrel.2015.10.005","volume":"219","author":"YH Yun","year":"2015","unstructured":"Yun YH, Lee BK, Park K (2015) Controlled drug delivery: historical perspective for the next generation. J Control Release 219:2\u20137","journal-title":"J Control Release"},{"issue":"1","key":"5901_CR143","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1056\/NEJMoa2308719","volume":"390","author":"AR Rezai","year":"2024","unstructured":"Rezai AR, D\u2019Haese PF, Finomore V, Carpenter J, Ranjan M, Wilhelmsen K, Mehta RI, Wang P et al (2024) Ultrasound blood-brain barrier opening and Aducanumab in Alzheimer\u2019s disease. N Engl J Med 390(1):55\u201362. https:\/\/doi.org\/10.1056\/NEJMoa2308719","journal-title":"N Engl J Med"},{"key":"5901_CR144","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.biochi.2017.12.015","volume":"147","author":"B Shui","year":"2018","unstructured":"Shui B, Tao D, Florea A, Cheng J, Zhao Q, Gu Y, Li W, Jaffrezic-Renault N, et al. (2018) Biosensors for Alzheimer\u2019s disease biomarker detection: a review. Biochimie 147:13\u201324","journal-title":"Biochimie"},{"issue":"35","key":"5901_CR145","doi-asserted-by":"publisher","first-page":"24139","DOI":"10.1021\/acsnano.4c05270","volume":"18","author":"G Kwak","year":"2024","unstructured":"Kwak G, Grewal A, Slika H, Mess G, Li H, Kwatra M, Poulopoulos A, Woodworth GF et al (2024) Brain nucleic acid delivery and genome editing via focused ultrasound-mediated blood-brain barrier opening and long-circulating nanoparticles. ACS Nano 18(35):24139\u201324153. https:\/\/doi.org\/10.1021\/acsnano.4c05270","journal-title":"ACS Nano"},{"issue":"36","key":"5901_CR146","doi-asserted-by":"publisher","first-page":"42411","DOI":"10.1021\/acsami.1c10325","volume":"13","author":"L Jiang","year":"2021","unstructured":"Jiang L, Gu Y, Du Y, Tang X, Wu X, Liu J (2021) Engineering exosomes endowed with targeted delivery of triptolide for malignant melanoma therapy. ACS Appl Mater Interfaces 13(36):42411\u201342428. https:\/\/doi.org\/10.1021\/acsami.1c10325","journal-title":"ACS Appl Mater Interfaces"},{"key":"5901_CR147","doi-asserted-by":"publisher","first-page":"11015","DOI":"10.2147\/ijn.S549893","volume":"20","author":"L Gao","year":"2025","unstructured":"Gao L, Wang J, Bi Y (2025) Nanotechnology for neurodegenerative diseases: recent progress in brain-targeted delivery, stimuli-responsive platforms, and organelle-specific therapeutics. Int J Nanomedicine 20:11015\u201311044. https:\/\/doi.org\/10.2147\/ijn.S549893","journal-title":"Int J Nanomedicine"},{"key":"5901_CR148","volume-title":"Infusion-based drug delivery to the brain: what\u2019s next?","author":"T Yuan","year":"2025","unstructured":"Yuan T, Yang Y, Zhan W, Rodriguez y Baena F, Dini D (2025) Infusion-based drug delivery to the brain: what\u2019s next?, vol vol 22. Taylor & Francis"},{"key":"5901_CR149","doi-asserted-by":"publisher","DOI":"10.1016\/j.mtbio.2025.101613","volume":"31","author":"N Mukerjee","year":"2025","unstructured":"Mukerjee N, Bhattacharya A, Maitra S, Kaur M, Ganesan S, Mishra S, Ashraf A, Rizwan M et al (2025) Exosome isolation and characterization for advanced diagnostic and therapeutic applications. Mater Today Bio 31:101613. https:\/\/doi.org\/10.1016\/j.mtbio.2025.101613","journal-title":"Mater Today Bio"},{"issue":"5","key":"5901_CR150","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1586\/14737175.2015.1028369","volume":"15","author":"A Burgess","year":"2015","unstructured":"Burgess A, Shah K, Hough O, Hynynen K (2015) Focused ultrasound-mediated drug delivery through the blood-brain barrier. Expert Rev Neurother 15(5):477\u2013491. https:\/\/doi.org\/10.1586\/14737175.2015.1028369","journal-title":"Expert Rev Neurother"},{"issue":"1","key":"5901_CR151","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-02035-4","volume":"9","author":"X Sun","year":"2024","unstructured":"Sun X, Setrerrahmane S, Li C, Hu J, Xu H (2024) Nucleic acid drugs: recent progress and future perspectives. Signal Transduct Target Ther 9(1):316. https:\/\/doi.org\/10.1038\/s41392-024-02035-4","journal-title":"Signal Transduct Target Ther"},{"issue":"18","key":"5901_CR152","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1056\/NEJMoa1702752","volume":"377","author":"RS Finkel","year":"2017","unstructured":"Finkel RS, Mercuri E, Darras BT, Connolly AM, Kuntz NL, Kirschner J, Chiriboga CA, Saito K et al (2017) Nusinersen versus sham control in infantile-onset spinal muscular atrophy. N Engl J Med 377(18):1723\u20131732. https:\/\/doi.org\/10.1056\/NEJMoa1702752","journal-title":"N Engl J Med"},{"issue":"1","key":"5901_CR153","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-02112-8","volume":"10","author":"M Liu","year":"2025","unstructured":"Liu M, Wang Y, Zhang Y, Hu D, Tang L, Zhou B, Yang L (2025) Landscape of small nucleic acid therapeutics: moving from the bench to the clinic as next-generation medicines. Signal Transduct Target Ther 10(1):73. https:\/\/doi.org\/10.1038\/s41392-024-02112-8","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"5901_CR154","doi-asserted-by":"publisher","first-page":"18","DOI":"10.4103\/1673-5374.343882","volume":"18","author":"M Garcia-Contreras","year":"2023","unstructured":"Garcia-Contreras M, Thakor AS (2023) Extracellular vesicles in Alzheimer\u2019s disease: from pathology to therapeutic approaches. Neural Regen Res 18(1):18\u201322. https:\/\/doi.org\/10.4103\/1673-5374.343882","journal-title":"Neural Regen Res"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-026-05901-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-026-05901-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-026-05901-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T08:04:21Z","timestamp":1778141061000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-026-05901-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":154,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["5901"],"URL":"https:\/\/doi.org\/10.1007\/s12035-026-05901-0","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"5 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"612"}}